Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0806 per EA under NDC 68462025701. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Feb 25, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462025701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090135FDA Approved
2/25/2010
TE Code
AB
On Market Since
2/25/2010
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0806 per EA |
|---|---|
| All-time high | $0.1534 (Apr 16, 2014) |
| All-time low | $0.0575 (Nov 20, 2024) |
| 52-week high | $0.0848 |
| 52-week low | $0.0795 |
| Median price | $0.0949 |
| Average price | $0.0977 |
| Largest weekly change | +39.8% (Dec 19, 2018) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0806 per EA (NDC 68462025701), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has declined 32.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since Nov 28, 2013, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0575 (Nov 20, 2024) to a high of $0.1534 (Apr 16, 2014), with a median of $0.0949 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROPINIROLE HCL 3 MG TABLET, is $0.0710 per EA — about 12% below ROPINIROLE HCL 3 MG TABLET.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 68462025701) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.